As HHS Secretary, Kennedy cut nearly $500 million in funding for mRNA vaccine research. While he says that the decision was made after looking at the science, health experts have heavily criticized ...

The clinical hold is due to questions about BX004’s nebulizer device, temporarily pausing US enrollment in the cystic ...

Pharm Exec unveils its new slate of rising leaders in the biopharma industry—profiling the stories of five executives ...

Rob Abbott, CEO, ISPOR, highlights how uniting regulators, payers, and academic leaders worldwide can accelerate access to innovative treatments and strengthen evidence-based healthcare.